Scotia Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-40,634
Closed -$135K 815
2016
Q1
$135K Sell
40,634
-90,682
-69% -$283K ﹤0.01% 643
2015
Q4
$650K Hold
131,316
0.01% 505
2015
Q3
$662K Buy
131,316
+5,331
+4% +$30.5K 0.02% 480
2015
Q2
$797K Sell
125,985
-6,160
-5% -$41.3K 0.02% 435
2015
Q1
$930K Buy
132,145
+2,927
+2% +$21.2K 0.02% 319
2014
Q4
$995K Sell
129,218
-2,508
-2% -$19.8K 0.03% 298
2014
Q3
$983K Buy
131,726
+9,497
+8% +$88.2K 0.02% 306
2014
Q2
$1.18M Buy
122,229
+5,389
+5% +$48K 0.03% 280
2014
Q1
$970K Buy
116,840
+15,991
+16% +$137K 0.02% 304
2013
Q4
$851K Buy
100,849
+9,720
+11% +$81.9K 0.02% 293
2013
Q3
$727K Buy
91,129
+23,927
+36% +$192K 0.02% 293
2013
Q2
$518K Buy
+67,202
New +$524K 0.02% 288

Other funds holding PDLI